(J&J recall slideshow updated with company's latest medicine recall)NEW YORK ( TheStreet) -- Medicine recalls that greatly defined Johnson & Johnson ( JNJ) last year continue to pester the company in 2011.
The health care sector's ties to the increasingly unpopular Affordable Care Act, plus an uncertain U.S. presidential picture, gives some financial experts pause.
Doug Kass shares his thoughts on soup, insurance and Starbucks.
If the polls are right and Hillary Clinton wins the White House, these five stocks stand to get an immediate and long-lasting boost.
Jim Cramer ponders why M&A is just the start of the story and also wonders what a Democratic sweep would do to the markets.